Results 151 to 160 of about 23,536 (264)

Effect of Non-nucleoside Resistance-Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights From the Real-World RELATIVITY Cohort. [PDF]

open access: yesOpen Forum Infect Dis
Rial-Crestelo D   +38 more
europepmc   +1 more source

Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing.

open access: yesJournal of Antimicrobial Chemotherapy, 2014
G. Melikian   +16 more
semanticscholar   +1 more source

Cumulative exposure to integrase inhibitors and metabolic factors as independent predictors of severe hepatic steatosis in people with HIV. [PDF]

open access: yesJ Antimicrob Chemother
Panza F   +11 more
europepmc   +1 more source

Prevalence and Severity of Potential Drug-Drug Interactions in People Living with HIV on Antiretroviral Therapy in the United States. [PDF]

open access: yesInfect Dis Ther
Fleming SP   +9 more
europepmc   +1 more source

Association between infant post-natal prophylaxis regimens and pretreatment HIV drug resistance in infected infants. [PDF]

open access: yesFront Epidemiol
Inzaule SC   +14 more
europepmc   +1 more source

HIV-1 integrase inhibitor resistance in viraemic-treated individuals and baseline capsid diversity relevant to future lenacapavir therapy. [PDF]

open access: yesJ Antimicrob Chemother
Abdullahi A   +12 more
europepmc   +1 more source

Long-term effectiveness of first-line non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in Ghana.

open access: yesJournal of Antimicrobial Chemotherapy, 2014
F. Sarfo   +5 more
semanticscholar   +1 more source

Patterns of HIV-1 Viral Load Suppression and Drug Resistance During the Dolutegravir Transition: A Population-based Longitudinal Study. [PDF]

open access: yesClin Infect Dis
Martin MA   +22 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy